News: Morning Agenda: Pfizer-Allergan Deal Revives Debate Over U.S. Taxes
Elliott Adds a Chief Executive | Ackman Raises Stake in Valeant | Diller’s Minifactory of Spinoffs Pays Off
News: Morning Agenda: Pfizer-Allergan Deal Revives Debate Over U.S. Taxes
Elliott Adds a Chief Executive | Ackman Raises Stake in Valeant | Diller’s Minifactory of Spinoffs Pays Off
News: Morning Agenda: Pfizer and Allergan Reach 0 Billion Deal
Puerto Rico’s Creditors Open to Debt Exchange | Petco Close to $ 4.7 Billion Sale to CVC and Canadian Pension Fund
Farhad and Mike’s Week in Tech: Turkeys, News and News Turkeys
On whether instant reactions to breaking news make it preferable to avoid the Internet and television altogether until facts are sorted from fiction.
News: Morning Agenda: New Proposals to Curb Tax Relocations
Banks Weighed Down by Piles of Leveraged Loans | Buffett’s Grandson Seeks a Different Investment Route | Square Shares Soar After Public Offering
News: Morning Agenda: Square Scales Down Valuation
Pfizer and Allergan Are Said to Be Near a Deal | Fed Signals Readiness for December Rate Rise
News: Morning Agenda: Lyft Is Said to Seek 0 Million
Appetite for Risky Loans Wanes | Air Liquide to Acquire Airgas | Canadian Pacific Takes Merger Bid to Norfolk Southern
News: Morning Agenda: Stocks Fall After Paris Attacks
Campaign Against Efforts to Restrict Arbitration | An Irresistible Tax Move for Pfizer | Two Competing Drugs and Billion-Dollar Questions
News: Morning Agenda: Anheuser-Busch InBev Finalizes SABMiller Deal
Dizzying Ride May Be Ending for Start-Ups | No Clear Answer on Director Pay | More Charges in Online Attack at JPMorgan
News: Morning Agenda: Ackman Defiant Over Valeant
Pimco Suit Highlights Murky Investor Fees | Canadian Pacific Said to Weigh Norfolk Southern Deal | Match Seeks $ 3.1 Billion Valuation
News: Morning Agenda: Bonus Pay on Wall Street Likely to Fall
A Tough Year for Hedge Funds, but Not Real Estate | Square Persists with I.P.O.
News: Morning Agenda: Former Traders Found Guilty in Libor Case
Goldman Tries New Policies to Keep Its Junior Bankers | Allergan Plays Coy Over Pfizer Talks
Great News! We’re Not Doomed to Soaring Health Care Costs
There are lots of different ways to read what is happening, but overall there does seem to be some lasting improvement.
News: Morning Agenda: The Bitcoin Resurgence
Interest Rate Increase in December Is Still Possible | A 1975 Law Complicates Puerto Rico’s Debt Crisis | Activists May Not Be That Myopic
News: Morning Agenda: Success of Goldman-Funded School Program Questioned
Regulators Unbundle Attractions of Mergers | Japan Post Makes a Strong Market Debut
News: Morning Agenda: Activision Blizzard to Buy Maker of Candy Crush
Religious Arbitration Used for Secular Disputes | Soros Withdraws $ 490 Million From Janus Capital
News Q’s | Cassini Seeks Insights to Life in Plumes of Enceladus, Saturn’s Icy Moon
What are some of the other places in our solar system where scientists think life could possibly have taken hold?
News: The Morning Agenda: The Privatization of the Justice System
Lessons in Investing From Valeant | HSBC Profit Jumps